Back to search

PES2020-Prosj.etabl.støtte H2020

“Remune” portfolio expansion to nutritionally complete product, production scale-up and business development including on-line marketing

Awarded: NOK 74,999

Project Number:


Project Period:

2020 - 2020

Funding received from:



Subject Fields:

Cancer cachexia occurs in approximately 30–50% of all cancer patients, depending on type and stage (up to 86% of advanced cancer patients), creating approximately a 3-million annual incident patient population in the US, Europe and Japan. Chronic obstructive pulmonary disease (COPD) Cachexia is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. The market entry model will be developed further during the proposal preparation stage together with the partners. In particular, on-line distribution model will be developed to reflect the situation our distributors are facing during the COVID-19 outbreak. Our estimates show that the product can generate revenues for Smartfish in order of €100 Mn in 5 years post-launch.

Funding scheme:

PES2020-Prosj.etabl.støtte H2020